Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.

Also called NCT05797519

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
VDyne, Inc. (from the registry)
Registry
  • NCT NCT05797519
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Australia, Austria, Belgium, Czechia, Denmark, Germany, Netherlands, New Zealand, Spain, Sweden, United Kingdom (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05797519. Allocation not applicable; no masking; primary purpose treatment. Start 2023-03-01 (actual); primary completion 2026-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation
Acronym
VISTA
Condition
Tricuspid Regurgitation
Condition
Tricuspid Valve Disease
Condition
Tricuspid Valvular Disorders
Intervention (Device)
VDyne Transcatheter Tricuspid Valve Replacement System
Lead sponsor
VDyne, Inc. (class: industry)

Record details

Record id
cardio:ct-nct05797519
Content hash
114e8cab554c1ed9e1a14a186b17b5bceadb0e0a83652bd3f622b6f496d5ab7d